New Elite Feature: Personalize Your Finviz Homepage

Crescent Biopharma, Inc.

Contributing Author

Recent Articles by Crescent Biopharma, Inc.

Jun-11	Crescent Biopharma Announces Grants of Inducement Awards CBIO GlobeNewswire
Jun-02	Crescent Biopharma to Present at June Investor Conferences CBIO -13.77% CBIO +5.73% GlobeNewswire
May-29	Crescent Biopharma Announces Grants of Inducement Awards CBIO GlobeNewswire
May-21	Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting CBIO +6.98% GlobeNewswire
May-12	Crescent Biopharma Announces Grants of Inducement Awards CBIO +6.23% CBIO GlobeNewswire
May-06	Crescent Biopharma to Present at May Investor Conferences CBIO GlobeNewswire
Apr-29	Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights CBIO -12.60% CBIO +6.83% GlobeNewswire
Apr-24	Crescent Biopharma Announces Grants of Inducement Awards CBIO GlobeNewswire
Mar-27	Crescent Biopharma Announces Grants of Inducement Awards CBIO +12.30% CBIO +9.63% GlobeNewswire
Mar-06	Crescent Biopharma Announces Grants of Inducement Awards CBIO +6.53% GlobeNewswire
Feb-26	Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CBIO GlobeNewswire
Feb-23	Crescent Biopharma to Present at March Investor Conferences CBIO GlobeNewswire
Feb-19	Crescent Biopharma Announces Grants of Inducement Awards CBIO +20.78% GlobeNewswire
Feb-18	Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors CBIO GlobeNewswire
Feb-05	Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 CBIO GlobeNewswire
Jan-30	Crescent Biopharma Announces Grants of Inducement Awards CBIO -5.47% GlobeNewswire
Jan-05	Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors CBIO GlobeNewswire
Dec-18	Crescent Biopharma Announces Grants of Inducement Awards CBIO GlobeNewswire
Dec-04	Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors CBIO GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)